Wellington Management Group
RARX

Wellington Management Group’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Wellington Management Group’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-182,245
Closed -$8.75M – 2056
2020
Q1 		$8.75M Sell
182,245
-74,194
-29% -$3.45M ﹤0.01% 1068
2019
Q4 		$12M Sell
256,439
-4,058,508
-94% -$179M ﹤0.01% 1121
2019
Q3 		$102M Sell
4,314,947
-865,221
-17% -$25.6M 0.02% 537
2019
Q2 		$156M Buy
5,180,168
+36,269
+0.7% +$831K 0.03% 441
2019
Q1 		$115M Sell
5,143,899
-114,053
-2% -$2.45M 0.03% 508
2018
Q4 		$95.7M Buy
5,257,952
+2,378,520
+83% +$37.3M 0.02% 523
2018
Q3 		$52.1M Buy
2,879,432
+3,795
+0.1% +$45K 0.01% 788
2018
Q2 		$28.6M Sell
2,875,637
-31,860
-1% -$220K 0.01% 969
2018
Q1 		$15.4M Buy
2,907,497
+140,254
+5% +$1M ﹤0.01% 1157
2017
Q4 		$23.5M Buy
2,767,243
+474,202
+21% +$5.83M 0.01% 1022
2017
Q3 		$33.5M Buy
2,293,041
+187,977
+9% +$2.84M 0.01% 886
2017
Q2 		$39.4M Buy
2,105,064
+473,635
+29% +$10.7M 0.01% 805
2017
Q1 		$34.7M Buy
1,631,429
+56,450
+4% +$1.08M 0.01% 848
2016
Q4 		$23.9M Buy
+1,574,979
New +$21.4M 0.01% 946

Other funds holding RARX

Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Wellington Management Group's RARX Position: Q2 2020 in Review

Wellington Management Group sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 182,245 shares — an estimated $8.75M sold.

Wellington Management Group first reported a position in RARX in Q4 2016 and held it in 14 quarters. The position peaked at $156M in Q2 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

  • Wellington Management Group reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Wellington Management Group sold 182,245 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $8.75M.
  • Wellington Management Group first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 14 quarters.
  • Wellington Management Group's Ra Pharmaceuticals, Inc. Common Stock position peaked at $156M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Wellington Management Group's 13F filing for Q2 2020, filed 14 Aug 2020.